VIELA BIO, INC. Operating Expenses
VIELA BIO, INC. reported Operating Expenses of $165.53 million for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2021-03-01
- VIELA BIO, INC. operating expenses for the quarter ending 2020-12-31 was $43.07M, a 0.15% increase year-over-year.
- VIELA BIO, INC. operating expenses for the quarter ending 2020-09-30 was $40.53M, a 17.16% decline year-over-year.
- VIELA BIO, INC. operating expenses for the quarter ending 2020-06-30 was $39.82M, a 52.53% increase year-over-year.
- VIELA BIO, INC. operating expenses for the quarter ending 2020-03-31 was $42.11M, a 94.49% increase year-over-year.
- VIELA BIO, INC. operating expenses for fiscal 2020 was $165.53M, a 18.50% increase from fiscal 2019.
- VIELA BIO, INC. operating expenses for fiscal 2019 was $139.69M, a 27.36% decline from fiscal 2018.
- VIELA BIO, INC. operating expenses for fiscal 2018 was $192.31M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2020-12-31 | $43.07M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $83.60M derived: sum of 2 quarters · filed 2021-03-01 | $123.42M derived: sum of 3 quarters · filed 2021-03-01 | $165.53M 10-K · filed 2021-03-01 |
| 2020-09-30 | $40.53M 10-Q · filed 2020-11-10 | $80.36M derived: sum of 2 quarters · filed 2020-11-10 | $122.47M 10-Q · filed 2020-11-10 | $165.47M derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-06-30 | $39.82M 10-Q · filed 2020-08-12 | $81.93M 10-Q · filed 2020-08-12 | $124.93M derived: sum of 3 quarters · filed 2021-03-01 | $173.86M derived: sum of 4 quarters · filed 2021-03-01 |
| 2020-03-31 | $42.11M 10-Q · filed 2020-05-13 | $85.11M derived: sum of 2 quarters · filed 2021-03-01 | $134.04M derived: sum of 3 quarters · filed 2021-03-01 | $160.15M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-12-31 | $43.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $91.93M derived: sum of 2 quarters · filed 2021-03-01 | $118.04M derived: sum of 3 quarters · filed 2021-03-01 | $139.69M 10-K · filed 2021-03-01 |
| 2019-09-30 | $48.93M 10-Q · filed 2020-11-10 | $75.04M derived: sum of 2 quarters · filed 2020-11-10 | $96.69M 10-Q · filed 2020-11-10 | $112.38M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $26.11M 10-Q · filed 2020-08-12 | $47.76M 10-Q · filed 2020-08-12 | $63.45M derived: sum of 3 quarters · filed 2021-03-01 | $79.78M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $21.65M 10-Q · filed 2020-05-13 | $37.34M derived: sum of 2 quarters · filed 2021-03-01 | $53.67M derived: sum of 3 quarters · filed 2021-03-01 | |
| 2018-12-31 | $15.69M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $32.02M derived: sum of 2 quarters · filed 2021-03-01 | $192.31M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $16.33M 10-Q · filed 2019-11-14 | $176.62M 10-Q · filed 2019-11-14 |